Zhihui Hao

Prof. Zhihui Hao


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Phytomedicine
Verified
Journal Article
Closed access
YWYuan-Yuan Wei
Yuan-Yuan Wei
YFYi-Meng Fan
Yi-Meng Fan
YGYu. Ga
Yu. Ga
YZYan-Nan Zhang
Yan-Nan Zhang
JHJun-Cheng Han
Jun-Cheng Han
ZHZhihui Hao
Zhihui Hao

14 October 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
CDChongshan Dai
Chongshan Dai
ETErjie Tian
Erjie Tian
ZHZhihui Hao
Zhihui Hao
STShusheng Tang
Shusheng Tang
Zhanhui WangZhanhui Wang
Zhanhui Wang
JSJianzhong Shen
Jianzhong Shen
One of the most significant classes of mycotoxins, aflatoxins (AFTs), can cause a variety of detrimental outcomes, including cancer, hepatitis, aberrant mutations, and reproductive issues. Among the 21 identified AFTs, aflatoxin B1 (AFB1) is the most harmful to humans and animals. The mechanisms of AFB1-induced toxicity are connected to the generation of excess reactive oxygen species (ROS), upregulation of CYP450 activities, oxidative stress, lipid peroxidation, apoptosis, mitochondrial dysfunction, autophagy, necrosis, and inflammatory response. Several signaling pathways, including p53, PI3K/Akt/mTOR, Nrf2/ARE, NF-κB, NLRP3, MAPKs, and Wnt/β-catenin have been shown to contribute to AFB1-mediated toxic effects in mammalian cells. Curcumin, a natural product with multiple therapeutic activities (e.g., anti-inflammatory, antioxidant, anticancer, and immunoregulation activities), could revise AFB1-induced harmful effects by targeting these pathways. Therefore, the potential therapeutic use of curcumin against AFB1-related side effects and the underlying molecular mechanisms are summarized. This review, in our opinion, advances significant knowledge, sparks larger discussions, and drives additional improvements in the hazardous examination of AFTs and detoxifying the application of curcumin.

9 November 2017 in Microbial Cell Factories
Verified
Journal Article
Open access
PDF file
JZJiajia Zhu
Jiajia Zhu
MGMingxing Gao
Mingxing Gao
RZRuili Zhang
Ruili Zhang
ZSZhuojian Sun
Zhuojian Sun
CWChunmei Wang
Chunmei Wang
ZHZhihui Hao
Zhihui Hao
The present study compared the effects of soybean meal fermented by three different probiotics organisms with non-fermented soybean meal on growth performance, serum parameters, immune chemistry and intestinal morphology in weaned piglets. One hundred and forty-four 35-day old crossbred (Duroc × Landrace × Yorkshire) piglets were randomly allocated into four different dietary treatments (n = 36 per group) containing 0, 5, 10 and 15% fermented soybean meal. The piglets fed fermented soybean meal showed an increase (p < 0.05) in average daily weight gain and a reduction in feed consumption (p < 0.05).The piglets fed 10 and 15% fermented soybean meal showed the greatest growth improvement with higher levels of serum alkaline phosphatase and total serum proteins. Serum urea nitrogen in the experimental group was significantly lower than control whereas serum IgG, IgM and IgA levels were all significantly higher. Moreover, villus height in the duodenum, jejunum, and ileum was significantly higher (p < 0.05) and the crypt depth was significantly lower (p < 0.05). The levels of the autophagy factor LC3B in piglets showed a downward trend in the jejunum and ileum compared to control. Fermented soybean meal could significantly improve the growth, immune function and intestinal health in weaned piglets, and the best effective benefits showed in 10% FSBM group.

1 January 2019 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
SQShaoqi Qu
Shaoqi Qu
CDCunchun Dai
Cunchun Dai
FLFengting Lang
Fengting Lang
LHLongfei Hu
Longfei Hu
QTQihe Tang
Qihe Tang
ZHZhihui Hao
Zhihui Hao
Nephrotoxicity is the major limiting factor for the clinical use of vancomycin (VCM) for treatment of serious infections caused by multiresistant Gram-positive bacteria. This study investigated the renal protective activity of rutin in a rat model of VCM-induced kidney injury in male Wistar rats.

30 July 2021 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
JCJingwen Cui
Jingwen Cui
WSWanrong Song
Wanrong Song
YJYi-Peng Jin
Yi-Peng Jin
HXHuihao Xu
Huihao Xu
KFKai Fan
Kai Fan
LJLin Jiahao
Lin Jiahao
As one of the conventional treatment methods, acupuncture is an indispensable component of Traditional Chinese Medicine. Currently, acupuncture has been partly accepted throughout the world, but the mechanism of acupuncture is still unclear. Since the theory of the neuro-endocrine-immune network was put forward, new insights have been brought into the understanding of the mechanism of acupuncture. Studies have proven that acupuncture is a mechanical stimulus that can activate local cell functions and neuroreceptors. It also regulates the release of related biomolecules (peptide hormones, lipid hormones, neuromodulators and neurotransmitters, and other small and large biomolecules) in the microenvironment, where they can affect each other and further activate the neuroendocrine-immune network to achieve holistic regulation. Recently, growing efforts have been made in the research on the mechanism of acupuncture. Some researchers have transitioned from studying the mechanism of acupuncture as a single linear pathway to using systems approaches, including metabolomics, genomics, proteomics and biological pathway analysis. This review summarizes the research progress on the neuro-endocrine-immune network related mechanism of acupuncture and discusses its current challenges and future directions.

22 November 2019 in Frontiers in Microbiology
Verified
Journal Article
Open access
SQShaoqi Qu
Shaoqi Qu
CDCunchun Dai
Cunchun Dai
ZSZhangqi Shen
Zhangqi Shen
QTQihe Tang
Qihe Tang
HWHaixia Wang
Haixia Wang
ZHZhihui Hao
Zhihui Hao
Treatment of multi-drug resistant (MDR) Escherichia coli intestinal infections are being hampered by the presence of the mcr-1 (colistin) and tet (tetracycline) resistance genes in these strains. We screened seven traditional Chinese medicines for their ability to synergize with tetracycline to provide an effective new drug for the treatment of animal intestinal diseases caused by MDR E. coli. Our primary screen identified quercetin as a compound that reduced the minimum inhibitory concentration (MIC) of tetracycline against the E. coli standard test strain American Type Culture Collection (ATCC) 25922 and clinical isolates fourfold from 4 and 256 μg/mL to 1 and 64 μg/mL, respectively. Low levels of quercetin in combination with tetracycline were bactericidal for clinical E. coli isolates and after 24 h, the differences between this combination and each drug singly were 108 CFU/mL. We used this combination therapy in a mouse infection model and found 100% survival after 48 h compared with <50% for each drug alone. This drug combination also synergized to disrupt the bacterial cell envelope resulting in increased permeability and cell lysis. These data demonstrate that combinatorial screening at low concentrations constitutes an efficient approach to identify clinically relevant quercetin/tetracycline combinations and is a valuable prototypical combination that has a high clinical potential against E. coli infections.